Antiviral escape strategies developed by bunyaviruses pathogenic for humans. 2012

Nicolas Le May, and Michele Bouloy
Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, Strasbourg, France. nlemay@igbmc.fr

New or re-emerging pathogens for humans have emerged outside of their usual endemic range during the last decade originating severe public health concern and economical losses. Climate changes have played a significant role in the emergence or re-emergence of arboviruses. Among these pathogens, several viruses belong to the Bunyaviridae family. This family is composed of RNA viruses grouped into five genera Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus and Tospovirus characterized by their antigenic, genetic and ecological properties. These viruses use cellular proteins to promote their own replication/transcription and reciprocally the host induces, in response, an important transcriptional reprogramming to activate antiviral defences including the interferon type I pathways. The virulence of the pathogenic bunyaviruses is directly linked to the roles of viral virulence factors and their capacity to counteract the host pathways. This review summarizes the various strategies developed by the different genera of the Bunyaviridae family to overcome and escape the innate immune response and eventually other cellular functions.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D002043 Bunyaviridae A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.
D002044 Bunyaviridae Infections Virus diseases caused by the BUNYAVIRIDAE. Bunyavirus Infections,Infections, Bunyaviridae,Infections, Bunyavirus,Oropouche Fever,Oropouche Infection,Oropouche Orthobunyavirus Infection,Oropouche Virus Infection,Orthobunyavirus Infections,Bunyaviridae Infection,Bunyavirus Infection,Oropouche Fevers,Orthobunyavirus Infection,Orthobunyavirus Infection, Oropouche,Virus Infection, Oropouche
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

Nicolas Le May, and Michele Bouloy
March 2021, Drug discovery today,
Nicolas Le May, and Michele Bouloy
January 2017, Current topics in microbiology and immunology,
Nicolas Le May, and Michele Bouloy
April 2000, Antimicrobial agents and chemotherapy,
Nicolas Le May, and Michele Bouloy
October 2011, Antiviral research,
Nicolas Le May, and Michele Bouloy
September 2003, Drugs of today (Barcelona, Spain : 1998),
Nicolas Le May, and Michele Bouloy
September 2002, Revista da Escola de Enfermagem da U S P,
Nicolas Le May, and Michele Bouloy
April 2008, The Journal of antimicrobial chemotherapy,
Nicolas Le May, and Michele Bouloy
March 2024, Molecular microbiology,
Nicolas Le May, and Michele Bouloy
January 2023, Frontiers in cellular and infection microbiology,
Copied contents to your clipboard!